{"title_page": "ExpreS2ion Biotechnologies", "text_new": "{{short description|Danish biotechnology company}}\n{{Infobox company \n|logo           = File:ExpreS2ion Biotechnologies logo.png\n|name           = ExpreS2ion Biotechnologies ApS\n|type           = \n|traded_as      = [[Nasdaq First North]]: [http://www.nasdaqomxnordic.com/aktier/microsite?languageId=1&Instrument=SSE125185= EXPRS2]\n|foundation     = 2010\n|location       = [[Horsholm]], [[Denmark]]\n|key_people     = Martin Roland Jensen (Chairman)<br>Bent U. Frandsen ([[Chief executive officer|CEO]])\n|industry       = [[Biotechnology]]\n|products       = [[Vaccine]]s and [[immunotherapy]] products\n|parent         = ExpreS2ion Biotech Holding AB\n|homepage       = [https://expres2ionbio.com/ www.expres2ionbio.com]\n|num_employees  = \n}}\n\n'''ExpreS2ion Biotechnologies''' is a [[Denmark|Danish]] biotechnology company specialised in the development of new [[vaccine]]s and [[immunotherapy]] products based in [[Horsholm]], [[Denmark]] and listed on the [[Nasdaq First North]] Growth Market [[Sweden]].<ref>{{cite web |title=The race to develop a coronavirus vaccine |url=https://eandt.theiet.org/content/articles/2020/04/the-race-to-develop-a-coronavirus-vaccine/ |website=[[Engineering & Technology]] |accessdate=25 April 2020}}</ref>\n\nExpreS2ion is part of the PREVENT-nCoV consortium comprising '''AdaptVac''' (a joint-venture between ExpreS2ion Biotechnologies and the [[University of Copenhagen]] spin-out NextGen Vaccines), [[Leiden University Medical Center]], [[Institute for Tropical Medicine T\u00fcbingen]], The Department of Immunology and Microbiology (ISIM) at the University of Copenhagen, and the Laboratory of Virology at [[Wageningen University and Research]].<ref>{{cite web |title=ExpreS2ion announces selection of AGC Biologics as manufacturing partner for the COVID-19 vaccine and provides update to the program |url=https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-selection-of-agc-biologics-as-manufacturing-partner-for-the-covid-19-vaccine-an,c3094798 |website=[[Cision]] |accessdate=25 April 2020}}</ref> In March 2020 the consortium was awarded an EU [[Horizon 2020]] grant of \u20ac2.7million for the development of a [[COVID-19 vaccine]] candidate, of which ExpreS2ion was funded with \u20ac0.88million.<ref>{{cite web |title=PREVENT-nCoV consortium announces EU grant award for COVID-19 vaccine development programme |url=https://www.medizin.uni-tuebingen.de/files/view/W0nPpDMa6lLgzbJo9VGLXAbO/200309%20Press%20release%20Covid-19%20consortium_final.pdf |accessdate=25 April 2020}}</ref><ref>{{cite web |title=ExpreS2ion announces EU grant award for the COVID-19 vaccine development programme |url=https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-eu-grant-award-for-the-covid-19-vaccine-development-programme,c3054055 |website=[[Cision]] |accessdate=25 April 2020}}</ref>\n\n==References==\n{{Reflist|2}}\n\n==External links==\n* [https://expres2ionbio.com/ ExpreS2ion Biotechnologies website]\n\n[[Category:Biotechnology companies of Denmark]]\n[[Category:Companies listed on the Stockholm Stock Exchange]]\n\n{{Denmark-company-stub}}\n", "text_old": "{{short description|Danish biotechnology company}}\n{{Infobox company \n|logo           = File:ExpreS2ion Biotechnologies logo.png\n|name           = ExpreS2ion Biotechnologies ApS\n|type           = \n|traded_as      = [[Nasdaq First North]]: [http://www.nasdaqomxnordic.com/aktier/microsite?languageId=1&Instrument=SSE125185= EXPRS2]\n|foundation     = 2010\n|location       = [[Horsholm]], [[Denmark]]\n|key_people     = Martin Roland Jensen (Chairman)<br>Bent U. Frandsen ([[Chief executive officer|CEO]])\n|industry       = [[Biotechnology]]\n|products       = [[Vaccine]]s and [[immunotherapy]] products\n|parent         = ExpreS2ion Biotech Holding AB\n|homepage       = [https://expres2ionbio.com/ www.expres2ionbio.com]\n|num_employees  = \n}}\n\n'''ExpreS2ion Biotechnologies''' is a [[Denmark|Danish]] biotechnology company specialised in the development of new [[vaccine]]s and [[immunotherapy]] products based in [[Horsholm]], [[Denmark]] and listed on the [[Nasdaq First North]] Growth Market [[Sweden]].<ref>{{cite web |title=The race to develop a coronavirus vaccine |url=https://eandt.theiet.org/content/articles/2020/04/the-race-to-develop-a-coronavirus-vaccine/ |website=[[Engineering & Technology]] |accessdate=25 April 2020}}</ref>\n\nExpreS2ion is part of the PREVENT-nCoV consortium comprising '''AdaptVac''' (a joint-venture between ExpreS2ion Biotechnologies and the [[University of Copenhagen]] spin-out NextGen Vaccines), [[Leiden University Medical Center]], [[Institute for Tropical Medicine T\u00fcbingen]], The Department of Immunology and Microbiology (ISIM) at the [[University of Copenhagen]], and the Laboratory of Virology at [[Wageningen University and Research]].<ref>{{cite web |title=ExpreS2ion announces selection of AGC Biologics as manufacturing partner for the COVID-19 vaccine and provides update to the program |url=https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-selection-of-agc-biologics-as-manufacturing-partner-for-the-covid-19-vaccine-an,c3094798 |website=[[Cision]] |accessdate=25 April 2020}}</ref> In March 2020 the consortium was awarded an EU [[Horizon 2020]] grant of \u20ac2.7million for the development of a [[COVID-19 vaccine]] candidate, of which ExpreS2ion was funded with \u20ac0.88million.<ref>{{cite web |title=PREVENT-nCoV consortium announces EU grant award for COVID-19 vaccine development programme |url=https://www.medizin.uni-tuebingen.de/files/view/W0nPpDMa6lLgzbJo9VGLXAbO/200309%20Press%20release%20Covid-19%20consortium_final.pdf |accessdate=25 April 2020}}</ref><ref>{{cite web |title=ExpreS2ion announces EU grant award for the COVID-19 vaccine development programme |url=https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-eu-grant-award-for-the-covid-19-vaccine-development-programme,c3054055 |website=[[Cision]] |accessdate=25 April 2020}}</ref>\n\n==References==\n{{Reflist|2}}\n\n==External links==\n* [https://expres2ionbio.com/ ExpreS2ion Biotechnologies website]\n\n[[Category:Biotechnology companies of Denmark]]\n[[Category:Companies listed on the Stockholm Stock Exchange]]\n\n{{Denmark-company-stub}}\n", "name_user": "Uhooep", "label": "safe", "comment": "", "url_page": "//en.wikipedia.org/wiki/ExpreS2ion_Biotechnologies"}
